Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
10/2005
10/19/2005EP1586556A2 Compounds to treat Alzheimer's disease
10/19/2005EP1585827A2 Modulation of protein functionalities
10/19/2005EP1585734A2 Anti-inflammatory medicaments
10/19/2005EP1585511A2 Asthma and allergic inflammation modulators
10/19/2005EP1423373B1 Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity
10/19/2005EP1389193B1 Method for producing biperiden i
10/19/2005EP1240142B1 New modulators of dopamine neurotransmission
10/19/2005CN1684958A Dihydro-dibenzo (A) anthracenes and relative compounds, composition and method
10/19/2005CN1684682A Small organic molecules that increase the activity of gelatinase A in ocular cells
10/19/2005CN1684678A Thiomolybdate analogues and uses thereof
10/19/2005CN1683592A Sulfur based corrosion inhibitors
10/19/2005CN1223348C N-(aryloxy group alkyl) heteroaromatic guadine and heteroaromatic guazine used as medicines
10/18/2005US6956988 Optical interleaver
10/18/2005US6956037 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/18/2005CA2240728C Kappa agonist compounds and pharmaceutical formulations thereof
10/18/2005CA2156288C Glycerol derivative, device and pharmaceutical composition
10/18/2005CA2137441C Amino-substituted benzenesulfonylureas and -thioureas, processes for their preparation, and their use as pharmaceuticals
10/13/2005WO2005095440A1 BETA-AMINOACID-DERIVATIVES AS FACTOR Xa INHIBITORS
10/13/2005WO2005095369A1 Water soluble esters of [n-(4-amino-2-butynyl)] with anticancer activity
10/13/2005WO2005095343A1 Dpp-iv inhibitors
10/13/2005WO2005095338A1 Alkoxyphenylpropanoic acid derivatives
10/13/2005WO2005095334A1 Sulfonamide compounds for the treatment of neurodegenerative disorders
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005094896A2 Targeted serotonin reuptake inhibitors
10/13/2005WO2005094805A1 Imine derivative and amide derivative
10/13/2005WO2005070910A3 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
10/13/2005WO2005067644A3 Conjugated small molecules
10/13/2005WO2005023183A3 Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use
10/13/2005WO2004113277A3 Methods and compositions for treating amyloid-related diseases
10/13/2005US20050228181 Serotonin receptor antagonists; nervous system disorders, R)-4-(2,3-dihydro-1,4-benzodioxin-5-yl)- beta -methyl-1-piperazineethanol
10/13/2005US20050228040 Bicyclic aromatic sulfinyl derivatives
10/13/2005US20050228036 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
10/13/2005US20050228021 Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
10/13/2005US20050228020 Beta secretase inhibitors
10/13/2005US20050228017 Novel anticancer compounds
10/13/2005US20050227995 Phenyl sulfoxides and phenyl sulfones
10/13/2005US20050227993 Novel analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders
10/13/2005US20050227991 Containing a piperazine ring, e.g., N'-(4-{4-[5-(1,2-dithiolan-3-yl)pentanoyl]-1-piperazinyl)phenyl)-2-thiophenecarboximidamide and intermediates for preparing them; useful for inhibiting NO synthase and regenerating antioxidants
10/13/2005US20050227990 Aminoalkoxy-functional chalcones
10/13/2005US20050227987 11beta-hydroxysteroid dehydrogenase inhibitors
10/13/2005US20050227982 Antileishmanial dinitroaniline sulfanomides with activity against parasite tubulin
10/13/2005US20050227979 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
10/13/2005US20050227974 Aminoalkyl-substituted aryl compounds and their use as sodium channel blockers
10/13/2005US20050227973 Human adam-10 inhibitors
10/13/2005US20050226844 Valency platform molecules comprising carbamate linkages
10/13/2005DE10392134T5 Azaphenylalaninderivate Azaphenylalaninderivate
10/13/2005CA2562114A1 Sulfonamide compounds for the treatment of neurodegenerative disorders
10/13/2005CA2559948A1 Beta-aminoacid-derivatives as factor xa inhibitors
10/13/2005CA2558446A1 Dpp-iv inhibitors
10/12/2005EP1583760A2 Substituted heterocyclic compounds
10/12/2005EP1583745A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
10/12/2005EP1387828B1 Method for producing biperiden iv
10/12/2005EP1202986B1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
10/12/2005EP1201235B1 Neuropathy improvers containing nitrogenous compounds as the active ingredient
10/12/2005CN1681797A Process for producing oxycarbonyl-substituted piperazine derivative
10/12/2005CN1681796A Process for the preparation of 4- (3'-chloro-4'-fluoroanilino) -7-methoxy-6- (3-morpholinopropoxy) quinazoline
10/12/2005CN1681775A N-hydroxyformamidine derivative
10/12/2005CN1681772A Succinic acid semi-amides as anti-corrosives agents
10/12/2005CN1681763A Chemical compounds
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2005CN1680279A Phenoxyhydrindone derivatives containing nitrogen and preparation and use thereof
10/12/2005CN1679472A Antimycotic nail varnish composition
10/12/2005CN1679406A Compound with vitamin k activity, particularly as additive for feeds, and preparation of the compound
10/12/2005CN1222521C Proces for synthesis of 5-(4-fluorophenyl)-1-[2R, 4R]-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxypic acid phenylamide
10/11/2005US6953858 A phenylalkyl secondary- and tertiary-amides enzyme inhibitors as viricides, for treating AIDS
10/11/2005US6953857 Oxybenzamide derivatives useful for inhibiting factor Xa or viia
10/11/2005US6953806 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/11/2005US6953801 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/11/2005US6953797 Nitric oxide synthase inhibitor; antiinflammatory agents
10/11/2005US6953796 Use of 2-amino-thiazoline derivatives as inhibitors of inducible No-synthase
10/11/2005US6953792 Cyclohexyl derivatives and their use as therapeutic agents
10/06/2005WO2005092899A1 Inhibitors of histone deacetylase
10/06/2005WO2005092840A1 Formamide derivatives useful as adrenoceptor
10/06/2005WO2005092836A1 Opioid receptor antagonists
10/06/2005WO2005092835A1 Pharmaceutical compounds
10/06/2005WO2005092832A1 Method of producing aminophenol compounds
10/06/2005WO2005092099A1 Hiv integrase inhibitors
10/06/2005WO2005092011A2 Mitotic kinesin inhibitors
10/06/2005US20050222423 Carboxylic acid derivative
10/06/2005US20050222414 N-(4-methylphenyl)-4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxamide; anticarcinogenic, antiproliferative agent; ovarian carcinoma, psoriasis; gene transcription control
10/06/2005US20050222255 Process for producing trans-4-amino-1-cyclohexanecarboxilic acid derivative
10/06/2005US20050222254 Sulfonamide compounds for the treatment of neurodegenerative disorders
10/06/2005US20050222244 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
10/06/2005US20050222243 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/06/2005US20050222200 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/06/2005US20050222146 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
10/06/2005US20050222140 Improved DP-IV inhibitors increase the steady state concentrations of GLP-1 and GIP, resulting in improved glucose tolerance
10/06/2005US20050222126 Antiangiogenic compounds and an assay for inhibitors of cell invasion
10/06/2005US20050221389 Organic reactions with CO generating materials
10/06/2005CA2560213A1 Mitotic kinesin inhibitors
10/06/2005CA2559733A1 Inhibitors of histone deacetylase
10/06/2005CA2557794A1 Opioid receptor antagonists
10/06/2005CA2557785A1 Hiv integrase inhibitors
10/05/2005EP1581511A1 Ccr8 inhibitors
10/05/2005EP1581510A2 1-aryl-2-hydroxyethyl amides as potassium channel openers
10/05/2005EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same
10/05/2005EP1581489A2 Compounds having prolyl oligopeptidase inhibitory activity
10/05/2005EP1581480A1 Cyclopentil-substituted glutaramide compounds as endopeptidasev inhibitors
10/05/2005EP1581476A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
10/05/2005EP1581467A2 Ligands for metals and improved metal-catalyzed processes based thereon
1 ... 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 ... 341